Cargando…

Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis

Second primary malignancies (SPMs) after liver transplantation (LT) are becoming the leading causes of death in LT recipients. The purpose of this study was to explore prognostic factors for SPMs and to establish an overall survival nomogram. METHODS: A retrospective analysis was conducted of data f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Qingbao, Wang, Keyu, Li, Yupeng, Peng, Peng, Zhang, Dongyuan, Chang, Donglei, Wang, Wentao, Ren, Lei, Tang, Fang, Li, Ziqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281177/
https://www.ncbi.nlm.nih.gov/pubmed/37145881
http://dx.doi.org/10.1097/COC.0000000000001004
_version_ 1785060956869492736
author Ding, Qingbao
Wang, Keyu
Li, Yupeng
Peng, Peng
Zhang, Dongyuan
Chang, Donglei
Wang, Wentao
Ren, Lei
Tang, Fang
Li, Ziqiang
author_facet Ding, Qingbao
Wang, Keyu
Li, Yupeng
Peng, Peng
Zhang, Dongyuan
Chang, Donglei
Wang, Wentao
Ren, Lei
Tang, Fang
Li, Ziqiang
author_sort Ding, Qingbao
collection PubMed
description Second primary malignancies (SPMs) after liver transplantation (LT) are becoming the leading causes of death in LT recipients. The purpose of this study was to explore prognostic factors for SPMs and to establish an overall survival nomogram. METHODS: A retrospective analysis was conducted of data from the Surveillance, Epidemiology, and End Results (SEER) database on adult patients with primary hepatocellular carcinoma who had undergone LT between 2004 and 2015. Cox regression analysis was used to explore the independent prognostic factors for SPMs. Nomogram was constructed using R software to predict the overall survival at 2, 3, and 5 years. The concordance index, calibration curves, and decision curve analysis were used to evaluate the clinical prediction model. RESULTS: Data from a total of 2078 patients were eligible, of whom 221 (10.64%) developed SPMs. A total of 221 patients were split into a training cohort (n=154) or a validation cohort (n=67) with a 7:3 ratio. The 3 most common SPMs were lung cancer, prostate cancer, and non-Hodgkin lymphoma. Age at initial diagnosis, marital status, year of diagnosis, T stage, and latency were the prognostic factors for SPMs. The C-index of the nomogram for overall survival in the training and validation cohorts were 0.713 and 0.729, respectively. CONCLUSIONS: We analyzed the clinical characteristics of SPMs and developed a precise prediction nomogram, with a good predictive performance. The nomogram we developed may help clinicians provide personalized decisions and clinical treatment for LT recipients.
format Online
Article
Text
id pubmed-10281177
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102811772023-06-21 Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis Ding, Qingbao Wang, Keyu Li, Yupeng Peng, Peng Zhang, Dongyuan Chang, Donglei Wang, Wentao Ren, Lei Tang, Fang Li, Ziqiang Am J Clin Oncol Original Articles: Gastrointestinal Second primary malignancies (SPMs) after liver transplantation (LT) are becoming the leading causes of death in LT recipients. The purpose of this study was to explore prognostic factors for SPMs and to establish an overall survival nomogram. METHODS: A retrospective analysis was conducted of data from the Surveillance, Epidemiology, and End Results (SEER) database on adult patients with primary hepatocellular carcinoma who had undergone LT between 2004 and 2015. Cox regression analysis was used to explore the independent prognostic factors for SPMs. Nomogram was constructed using R software to predict the overall survival at 2, 3, and 5 years. The concordance index, calibration curves, and decision curve analysis were used to evaluate the clinical prediction model. RESULTS: Data from a total of 2078 patients were eligible, of whom 221 (10.64%) developed SPMs. A total of 221 patients were split into a training cohort (n=154) or a validation cohort (n=67) with a 7:3 ratio. The 3 most common SPMs were lung cancer, prostate cancer, and non-Hodgkin lymphoma. Age at initial diagnosis, marital status, year of diagnosis, T stage, and latency were the prognostic factors for SPMs. The C-index of the nomogram for overall survival in the training and validation cohorts were 0.713 and 0.729, respectively. CONCLUSIONS: We analyzed the clinical characteristics of SPMs and developed a precise prediction nomogram, with a good predictive performance. The nomogram we developed may help clinicians provide personalized decisions and clinical treatment for LT recipients. Lippincott Williams & Wilkins 2023-07 2023-05-05 /pmc/articles/PMC10281177/ /pubmed/37145881 http://dx.doi.org/10.1097/COC.0000000000001004 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Articles: Gastrointestinal
Ding, Qingbao
Wang, Keyu
Li, Yupeng
Peng, Peng
Zhang, Dongyuan
Chang, Donglei
Wang, Wentao
Ren, Lei
Tang, Fang
Li, Ziqiang
Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis
title Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis
title_full Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis
title_fullStr Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis
title_full_unstemmed Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis
title_short Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation: A SEER-based Analysis
title_sort clinical characteristics and survival analysis of patients with second primary malignancies after hepatocellular carcinoma liver transplantation: a seer-based analysis
topic Original Articles: Gastrointestinal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281177/
https://www.ncbi.nlm.nih.gov/pubmed/37145881
http://dx.doi.org/10.1097/COC.0000000000001004
work_keys_str_mv AT dingqingbao clinicalcharacteristicsandsurvivalanalysisofpatientswithsecondprimarymalignanciesafterhepatocellularcarcinomalivertransplantationaseerbasedanalysis
AT wangkeyu clinicalcharacteristicsandsurvivalanalysisofpatientswithsecondprimarymalignanciesafterhepatocellularcarcinomalivertransplantationaseerbasedanalysis
AT liyupeng clinicalcharacteristicsandsurvivalanalysisofpatientswithsecondprimarymalignanciesafterhepatocellularcarcinomalivertransplantationaseerbasedanalysis
AT pengpeng clinicalcharacteristicsandsurvivalanalysisofpatientswithsecondprimarymalignanciesafterhepatocellularcarcinomalivertransplantationaseerbasedanalysis
AT zhangdongyuan clinicalcharacteristicsandsurvivalanalysisofpatientswithsecondprimarymalignanciesafterhepatocellularcarcinomalivertransplantationaseerbasedanalysis
AT changdonglei clinicalcharacteristicsandsurvivalanalysisofpatientswithsecondprimarymalignanciesafterhepatocellularcarcinomalivertransplantationaseerbasedanalysis
AT wangwentao clinicalcharacteristicsandsurvivalanalysisofpatientswithsecondprimarymalignanciesafterhepatocellularcarcinomalivertransplantationaseerbasedanalysis
AT renlei clinicalcharacteristicsandsurvivalanalysisofpatientswithsecondprimarymalignanciesafterhepatocellularcarcinomalivertransplantationaseerbasedanalysis
AT tangfang clinicalcharacteristicsandsurvivalanalysisofpatientswithsecondprimarymalignanciesafterhepatocellularcarcinomalivertransplantationaseerbasedanalysis
AT liziqiang clinicalcharacteristicsandsurvivalanalysisofpatientswithsecondprimarymalignanciesafterhepatocellularcarcinomalivertransplantationaseerbasedanalysis